+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effect of non-random missing data mechanisms in clinical trials



Effect of non-random missing data mechanisms in clinical trials



Statistics in Medicine 14(24): 2675-2684



A simple form of non-ignorable missing data mechanisms based on two parameters is used to characterize the amount of missing data and the severity of non-randomness in clinical trials. Based on the formulation, the effect of non-randomly missing data on simple analyses which ignore the missing data is studied for binary and normally distributed response variables. In general, the effect of the non-randomly missing data on the bias and the power increases with the severity of non-randomness. The bias can be positive or negative and the power can be less than or greater than when the data are missing at random. The results of the analysis, ignoring the missing data, can be seriously flawed if the non-randomness is severe, even when only a small proportion of the sample is missing. The problem is more pronounced in the case of normally distributed response variables with unequal variances.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 008540368

Download citation: RISBibTeXText

PMID: 8619107

DOI: 10.1002/sim.4780142407


Related references

Random-effects meta-analysis for systematic reviews of phase I clinical trials: Rare events and missing data. Research Synthesis Methods 8(2): 124-135, 2017

Stratified tests, stratified slopes, and random effects models for clinical trials with missing data. Journal of Biopharmaceutical Statistics 10(4): 447-455, 2000

An alternative way to classify missing data mechanism in clinical trials--a dialogue on missing data. Journal of Biopharmaceutical Statistics 21(2): 355-361, 2011

On random sample size, ignorability, ancillarity, completeness, separability, and degeneracy: sequential trials, random sample sizes, and missing data. Statistical Methods in Medical Research 23(1): 11-41, 2014

Missing inaction: preventing missing outcome data in randomized clinical trials. Journal of Biopharmaceutical Statistics 19(6): 957-968, 2009

A 'missing not at random' (MNAR) and 'missing at random' (MAR) growth model comparison with a buprenorphine/naloxone clinical trial. Addiction 110(1): 51-58, 2015

Missing not at random models for masked clinical trials with dropouts. Clinical Trials 12(2): 139-148, 2015

Coping with missing data in clinical trials: A model-based approach applied to asthma trials. Statistics in Medicine 21(8): 1043-1066, 30 April, 2002

Comparability of item quality indices from sparse data matrices with random and non-random missing data patterns. Journal of Applied Measurement 12(4): 358-369, 2011

A shared random effect parameter approach for longitudinal dementia data with non-ignorable missing data. Statistics in Medicine 23(2): 211-219, 2004

A comparison of missing data methods for hypothesis tests of the treatment effect in substance abuse clinical trials: a Monte-Carlo simulation study. Substance Abuse Treatment Prevention and Policy 3: 13, 2008

'Intention-to-treat' meets 'missing data': Implications of alternate strategies for analyzing clinical trials data. Drug and Alcohol Dependence 68(2): 121-130, 1 October, 2002

Missing data in clinical trials. New England Journal of Medicine 367(26): Author Reply 2557-8, 2013